The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence

Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010

Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors.

Oncogene·2006

Peritoneal mesothelioma.

Current treatment options in oncology·2002

Chemotherapy for malignant mesothelioma.

Seminars in thoracic and cardiovascular surgery·1997

Chemotherapy for advanced sarcoma: therapeutic decisions and modalities.

Seminars in oncology·1997